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Predicting the health effects of combined 
exposures from food, therapeutic treatments, 
and living or working environment is a long-
standing challenge to toxicology. If additiv-
ity is assumed, toxic equivalency factors can 
be used (Walker et al. 2005). Otherwise the 
whole mixture, assuming that it is sufficiently 
well defined, can be tested as a single entity. 
Yet, that offers little mechanistic insight or pre-
dictive capacity for the vast majority of real-life 
mixed exposures. The challenge to mechanistic 
studies lies in accounting for the possible non-
linear interactions between substances at the 
pharmacokinetic, metabolic, or pharmacody-
namic levels. They should also avoid the “curse 
of dimensionality,” which can affect experi-
mental and modeling approaches. For exam-
ple, assessing pairwise interactions between n 
substances requires a number of assays or anal-
yses proportional to n(n – 1)/2, the number of 
pairs to examine. For higher-order interactions, 
between triples, quadruples, and so forth, the 
number of assays grows with the cube, the 
quartic, and so on, of n. To avoid the curse of 
dimensionality, one can stay within the lim-
its of four to five substances in the mixtures 
considered. The published modeling literature 
does not venture much beyond those bounds 
(Haddad et al. 1999, 2000), even though real-
istic mixtures are much more complex.
To tackle mechanistically the question 
of realistic mixtures, we recently proposed 
a systems biology approach that, in its sim-
plest form, addresses metabolic interactions 
(Bois 2009b, 2009c). Our approach uses the 
combined ingredients of generic (substance-
independent) physiologically based pharma-
cokinetic (PBPK) modeling, systems biology 
markup language (SBML) modeling of meta-
bolic networks, detailed (non-Michaelian) 
description of enzymatic reactions, and auto-
matic code generation. Until now, we have 
used it only in a simulation complex, without 
confrontation with actual data. In this article, 
we present results of its application to mix-
tures of benzene, toluene, ethylbenzene, and 
m-xylene (BTEX), for which we have good 
data. We built and calibrated a predictive inter-
action model using single-chemical exposure 
data to obtain enzymatic microconstant values 
for benzene, toluene, ethylbenzene, and m-xy-
lene individually. We then used the model 
to predict metabolic interactions in BTEX 
mixtures. We compared the resulting predic-
tions with experimental mixture data and we 
explored the sensitivity of the predictions with 
respect to model structure.
Materials and Methods
PBPK model. Figure 1 shows the structure of 
the generic PBPK rat model used for each of 
the four chemicals investigated. That model 
served as an automatic template for generat-
ing absorption, transport, and excretion terms 
in the global model equations; it does not 
describe metabolism. Substances were assumed 
to partition between the liver, fat, poorly per-
fused or well perfused tissues, exhaled air, arte-
rial blood, and venous blood, as reported by 
Haddad et al. (1999). Only inhalation was 
modeled. The differential equations describing 
the time evolution of the quantity Qi of a sub-
stance in liver, fat, and poorly perfused or well 
perfused tissues were of the form
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where Fi is blood flow through tissue i 
(i – 1, . . . , 4), Vi is its volume, Pi is the cor-
responding tissue/blood partition coefficient, 
and Cart is the arterial blood concentration. 
Concentration dynamics in venous blood 
(Cven), arterial blood (Cart), and exhaled air 
(Cexh) were described by algebraic equations:
  C
F
F VP
Q
i
i
i
ii
i
i
ven =
cm
/
/
,  [2]
  , C
F P
F
FC CF
i
i
i
i
art
art
alv
alvi nh ven
=
+
+
/
/
  [3]
  .. , C P
C
C 07 03 exh
art
art
inh =+  [4]
where Falv is alveolar ventilation rate, Cinh is 
the inhaled substance concentration in air, 
and Part is the blood/air partition coefficient. 
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Ba c k g r o u n d: Computational modeling of the absorption, distribution, metabolism, and excretion 
of chemicals is now theoretically able to describe metabolic interactions in realistic mixtures of tens 
to hundreds of substances. That framework awaits validation.
oBjectives: Our objectives were to a) evaluate the conditions of application of such a framework, 
b) confront the predictions of a physiologically integrated model of benzene, toluene, ethylbenzene, 
and m-xylene (BTEX) interactions with observed kinetics data on these substances in mixtures and, 
c) assess whether improving the mechanistic description has the potential to lead to better predic-
tions of interactions.
Me t h o d s : We developed three joint models of BTEX toxicokinetics and metabolism and calibrated 
them using Markov chain Monte Carlo simulations and single-substance exposure data. We then 
checked their predictive capabilities for metabolic interactions by comparison with mixture kinetic data.
re s u l t s: The simplest joint model (BTEX interacting competitively for cytochrome P450 2E1 
access) gives qualitatively correct and quantitatively acceptable predictions (with at most 50% devia-
tions from the data). More complex models with two pathways or back-competition with metabolites 
have the potential to further improve predictions for BTEX mixtures.
co n c l u s i o n s: A systems biology approach to large-scale prediction of metabolic interactions is 
advantageous on several counts and technically feasible. However, ways to obtain the required 
parameters need to be further explored.
key w o r d s : MCMC, metabolic interactions, PBPK model, reaction network, systems biology. 
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Baseline PBPK model parameters values are 
reported in Tables 1 and 2. Some parameters 
were treated as random variables and assigned 
statistical distributions as explained below, 
but their sampling distributions stayed cen-
tered on their baseline values.
SBML models of metabolic reactions. 
For each chemical, the basic steps of its cyto-
chrome P450 2E1 (CYP2E1)-catalyzed oxida-
tion were coded in an SBML model (Hucka 
et al. 2003). Figure 2 shows the correspond-
ing model for benzene. In rats, BTEX com-
ponents are primarily oxidized by CYP2E1, 
giving rise to benzene oxide (Golding et al. 
2010), phenylmethanol (or benzyl alcohol) 
(Nakajima 1997), 1-phenylethanol (Saghir 
et al. 2009), and (3-methylphenyl) metha-
nol (or 3-methylbenzyl alcohol) (Nakajima 
1997), respectively. Four basic SBML models 
(type I models, one for each chemical) were 
developed with the following four differential 
equations (using benzene, B, as an example):
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where k1B, k2B, and k3B are the reactions’ 
microconstants for benzene. When comput-
ing, we actually used the quantity of CYP2E1 
in the liver, which is the product of liver vol-
ume (Vliver) and the CYP2E1 concentration 
in the above equations.
Two sets of alternative SBML   models 
(type II and type III models) were also 
coded to explore the effect of more complex 
metabolism. In type II models (Figure 3), 
benzene, toluene, ethylbenzene, or m-xylene 
can be metabolized by a second, unspecified 
enzyme, CYPX. The corresponding differen-
tial equations have additional terms, similar to 
those in Equations 5–8, for the new reactions. 
Type III models (Figure 4) considered the 
competition of the metabolites formed with 
their parents at the active site of CYP2E1. In 
all cases, the total quantities of CYP2E1 and 
CYPX enzymes were assumed to be constant 
over time.
Automatic code generation for global 
model. A C language file coding the complete 
set of differential equations describing the 
joint transport and metabolism of the four 
substances (“global model,” in the follow-
ing) was automatically generated from the 
individual SBML metabolic pathway files and 
compiled by GNU MCSim (version 5.3.1; 
http://www.gnu.org/software/mcsim/). The 
transport terms, based on the PBPK tem-
plate presented above, were generated for 
each chemical species placed outside the liver 
cell compartment in SBML. Species placed 
in the liver (e.g., CYP2E1) were not trans-
ported. Interactions implied by the competi-
tion for the same enzyme(s) are automatically 
taken into account; for example, in type I 
models, benzene, toluene, ethylbenzene, and 
m-xylene all bind competitively to CYP2E1 
Table 1. Chemical-independent model parameter 
baseline values.
Parameter Valuea
Total quantity of CYP2E1 (mmol) 2.09 × 10–5b
Alveolar ventilation rate (mL/min) 62.5c
Cardiac output (mL/min) 62.5c
Fraction of cardiac output to compartments
Liver 0.25
Fat 0.09
Poorly perfused tissues 0.15
Richly perfused tissues 0.51d
Total body volume (mL) 250
Volume of compartments (mL)
Liver 10
Fat 17.5c
Richly perfused tissues 12.5
Poorly perfused tissues 185e
aData from U.S. Environmental Protection Agency (1988), 
except for CYP2E1 quantity. bData from Carlile et al. (1997) 
and Seaton et al. (1995). cSubsequently sampled from 
statistical distributions (see “Materials and Methods”), 
using the given values as means. dComputed as 1.0 minus 
the sum of the other cardiac output fractions. eComputed 
as 0.9 times total body volume minus the sum of the other 
tissue volumes.
Figure 1. Generic rat PBPK template model used 
for each of the four BTEX constituents. C, concen-
tration of BTEX constituent.
C inhaled
Arterial
blood
Venous
blood
C exhaled
Poorly perfused
Well perfused
Fat
Liver
Table 2. Chemical-dependent model parameters and baseline values.
Parameter Benzenea Tolueneb Ethylbenzeneb m-Xyleneb
Partition coefficients
Blood/air 15c 18c 42.7c 46c
Liver/blood 1.13 4.64 1.96 1.97
Fat/blood 33.3 56.7 36.4 40.4
Poorly perfused/blood 1.0 1.54 0.61 0.91
Richly perfused/blood 1.13 4.64 1.41 1.97
Reaction rate constants
k1 (min–1 × nmol–1) —c —c —c —c
k2 (min–1) —c —c —c —c
k3 (min–1) 13.54c 10.38c 13.7c 10.32c
aData from Travis et al. (1990), except for k1, k2, and k3 (from Dennison et al. 2003). bData from Tardif et al. (1997), except 
for k1 and k2. cNo set baseline value, parameter subsequently sampled from statistical distributions and estimated in this 
study (see Table 3 and “Materials and Methods”).
Figure 2. Graphical representation of the baseline SBML model used to describe benzene oxidation into 
benzene oxide by CYP2E1. Three rate constants, k1, k2, and k3, are used. Similar models were built for 
  ethylbenzene, toluene, and m-xylene.
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(Equations 5–8). Therefore, the differential 
equation for free CYP2E1 is given by
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The corresponding joint metabolic network 
of BTEX, without the PBPK part, is illustrated 
in Figure 5. With steady-state and rapid equi-
librium assumptions, the full system of dif-
ferential equations could be simplified to yield 
the usual interaction parameters ki as func-
tions of the microconstants (Segel 1975). Such 
Michaelian treatment would be an approxima-
tion of our general solution, which does not 
require inter  action parameters because meta-
bolic inter  actions are automatically accounted 
for through the depletion of free CYP2E1.
Type I model calibration and predictions. 
The available literature only reports values for 
maximum velocity (Vmax) and the Michaelis 
constant (Km) (Haddad et al. 1999, 2001), 
whereas our formulation requires the micro-
constants k1, k2, and k3 for each component 
of BTEX. Indeed, Vmax, Km, k1, k2, and k3 are 
linked through classical relationships (Segel 
1975):
  , CYP2E1 Vk max total 3 # = 6@   [10]
  , K k
kk
m
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  [11]
but knowledge of Vmax and Km leaves one of 
the microconstants unspecified. Therefore, we 
obtained values for k1, k2, and k3 by Bayesian 
calibration (Bernillon and Bois 2000) of the 
global model type I to kinetic data on venous 
blood concentrations of benzene, toluene, eth-
ylbenzene, or m-xylene administered alone 
to rats (inhalation exposures to 50, 100, or 
200 ppm in the air) (Haddad et al. 2000). 
We first performed a Monte Carlo sensitiv-
ity analysis of benzene data (as described by 
Haddad et al. 2000) to check which flows, vol-
umes, and benzene-specific parameters needed 
to be calibrated. Most model parameters were 
sampled uniformly within ±10% of their base-
line values (Tables 1, 2). Parameters k1, k2, 
and k3 were sampled uniformly in the intervals 
[106, 107], [5, 15], and [2, 25] respectively. 
We calculated correlations between sampled 
parameter values and predicted benzene venous 
concentration at each measurement time after 
cessation of exposure to 50, 100, 200, or 500 
ppm of benzene in the air. Parameters with at 
least one correlation coefficient absolute value 
exceeding 0.3 were regarded as sensitive. The 
results [Supplemental Material, Tables S1, S2 
(http://dx.doi.org/10.1289/ehp.1103510)] 
indicated that, besides k3, the volume of fat, 
alveolar ventilation rate, cardiac output, and 
blood/air partition coefficient were sensitive. 
These parameters were therefore treated as 
random variables and sampled. Given the 
similarity of the kinetics of benzene, toluene, 
ethylbenzene, and m-xylene, we fitted the 
Figure 3. Graphical representation of the SBML model type II used to describe benzene oxidation into 
benzene oxide by two concurrent cytochromes. Six rate constants (k1, k2, k3, k1 ´, k2 ´, k3 ´) are needed. Similar 
models were built for ethylbenzene, toluene, and m-xylene.
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Figure 4. Graphical representation of the SBML model type III used to describe the competition between ben-
zene and its metabolites for access to CYP2E1. Seven rate constants are needed. kh, first order rate constant 
for benzene oxide to phenol conversion. Similar models were built for ethylbenzene, toluene, and m-xylene.
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same parameters for the other three BTEX 
components as well.
Bayesian calibration was performed using 
Markov chain Monte Carlo (MCMC) simula-
tions. The volume of fat, alveolar ventilation 
rate, cardiac output, and blood/air partition 
coefficient were sampled according to informa-
tive prior distributions (Table 3). Parameters 
k1 and k2 were sampled from wide uniform 
distributions, with informative bounds given 
by Segel (1975, p. 32). For k3 we used a nar-
rower range because we had reasonable prior 
values for benzene, toluene, ethylbenzene, 
and m-xylene Vmax (Bois and Paxman 1992; 
Dennison et al. 2003; Tardif et al. 1997) and 
for the total quantity of CYP2E1 in liver, hence 
for its total liver concentration [CYP2E1]total 
(Carlile et al. 1997; Seaton et al. 1995).
The data were assumed to be log-normally 
distributed with a geometric mean predicted 
by the model and a geometric standard devia-
tion (SD) computed from the arithmetic SD 
given for each data point by Haddad et al. 
(2000). The geometric SDs had an average of 
1.28. Hence variability appeared small in this 
data set, and we used the average concentra-
tions (for five rats) for each time point as data.
To obtain samples from the joint poste-
rior distribution of the model parameters, five 
Markov chains were run independently for each 
chemical. Their convergence was assessed using 
Gelman and Rubin’s (1992) R diagnostic.
As a cross-validation, the last step was to 
perform posterior predictive simulations of 
the kinetics of benzene, toluene, ethyl  benzene, 
and m-xylene administered together in vari-
ous mixture combinations. We simulated the 
mixture dosing conditions of Haddad et al. 
(1999) and Tardif et al. (1996) with the 
global model and parameter values from the 
joint posterior sample obtained by MCMC 
simulations. To simulate experimental error 
and interindividual variability, we added a 
log-normal noise with a geometric mean of 1 
and geometric SD of 1.28, consistent with the 
above error model.
Type II and III model predictions. Those 
models are more complex and each require 
12 additional reaction microconstants. We 
had no hope of identifying them with the data 
available and therefore set them to plausible 
values. For the parameters common to all three 
models (e.g., organ volumes), we used the pos-
terior values of global model I (Tables 1–3). 
For global model II, k2 ´ and k3 ´ for CYPX were 
set at the same values (or distribution) as for 
CYP2E1, but CYPX k1 ´ was set to 1/10 of 
CYP2E1 k1. CYPX therefore behaves as a 
lower affinity, lower capacity pathway than 
CYP2E1. The total quantity of CYPX in rat 
liver was set at 1.16 × 10–6 mmol, similar to 
that of CYP2B1 (Ngui and Bandiera 1999). 
For the type III global model, the parameters 
of the metabolites were set equal to those of 
the parents.
Software used. SBML metabolism models 
were individually coded using CellDesigner® 
(version 4.1; Funahashi et al. 2003). GNU 
MCSim (version 5.3.1; Bois 2009a; Bois and 
Maszle 1997) was used to build the PBPK 
model template and the global model and 
for the computations. R software (version 
2.11.0; R Development Core Team 2010) 
was used for graphics. The SBML files, the 
Figure 5. Graphical representation of the type I global metabolic interaction SBML model used for calibration 
and main predictions. BTEX components are circulated in the PBPK model shown in Figure 1. Their metabo-
lites are not tracked by the model equations. Interactions occur through the depletion of the CYP2E1 pool.
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Table 3. Prior distributions and posterior distribution summaries of the model parameters calibrated by 
MCMC sampling.
Parameter Prior distribution Posterior distributiona
Alveolar ventilation rate (mL/min) LN(62.5, 1.1) 78; 78 ± 5.6 (67, 89)
Cardiac output (mL/min) LN(62.5, 1.1) 90; 88 ± 6.8 (75, 100)
Volume of fat (mL) LN(17.5, 1.1) 12; 11.7 ± 0.8 (10, 13)
Blood/air partition coefficients
Benzene LN(15, 1.1) 15.4; 16 ± 1.2 (14, 19)
Toluene LN(18, 1.1) 17.2; 18 ± 1.7 (15, 22)
Ethylbenzene LN(42.7, 1.1) 40.3; 43 ± 4.0 (36, 52)
m-Xylene LN(46, 1.1) 48.5; 47 ± 4.5 (38, 56)
k1 rate constant (min–1 × nmol–1)
Benzene U(10–3, 102) 39; 66 ± 22 (20, 98)
Toluene U(10–3, 102) 26; 66 ± 22 (20, 98)
Ethylbenzene U(10–3, 102) 94; 65 ± 23 (19, 98)
m-Xylene U(10–3, 102) 61; 65 ± 22 (21, 98)
k2 rate constant (min–1)
Benzene U(10, 107) 1,040; 1,900 ± 900 (480, 3,900)
Toluene U(10, 107) 2,900; 8,400 ± 4,500 (1,700, 19,000)
Ethylbenzene U(10, 107) 22,000; 17,000 ± 6,600 (4,500, 29,000)
m-Xylene U(10, 107) 6,800; 9,000 ± 4,000 (2,400, 1,8000)
k3 rate constant (min–1)
Benzene U(2, 50) 7.8; 8.3 ± 1.0 (6.4, 10)
Toluene U(2, 50) 12; 13 ± 1.6 (10, 16)
Ethylbenzene U(2, 50) 17; 18 ± 1.8 (15, 22)
m-Xylene U(2, 50) 18; 19.5 ± 2.5 (15, 25)
Abbreviations: LN, lognormal; U, uniform. 
aValues shown are mode; mean ± SD (2.5th percentile, 97.5th percentile).Cheng and Bois
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PBPK template, and the global model files are 
provided as Supplemental Material (http://
dx.doi.org/10.1289/ehp.1103510).
Results
Model calibration using individual benzene, 
toluene, ethylbenzene, or m-xylene exposures. 
Global model type I (see Figures 1, 2, 5) was 
calibrated on the basis of rat exposures to sin-
gle substances (Haddad et al. 2000). Venous 
blood concentration data were measured at 
five time points during the 2 hr after a 4-hr 
inhalation exposure to 50, 100, or 200 ppm 
of each substance. Convergence of the five 
MCMC chains was obtained after 100,000 
iterations (R diagnostic < 1.021 for any param-
eter). The following results were obtained 
using 10,000 joint posterior parameter sam-
ples. Table 3 summarizes the posterior distri-
butions. Most parameters were well identified, 
with larger uncertainties about the k1 and k2 
rate constants (about 20–50% coefficient of 
variation). We used Equation 11 to compute 
Km values corresponding to the sampled k1, 
k2, and k3 values and compared them with 
previously published values [see Supplemental 
Material, Table S3 (http://dx.doi.org/10.1289/
ehp.1103510)]. Figure 6 shows the maximum 
posterior fit of the type I global model to the 
single-exposure data.
Model predictions and cross-validation for 
BTEX mixtures. Figure 7 shows box plots of 
the type I global model predictions of BTEX 
venous blood concentrations in rats after a 
quaternary mixture exposure (4 hr to 100 ppm 
benzene and 50 ppm for the other three com-
pounds). The corresponding data (Haddad 
et al. 1999) are overlaid for comparison. These 
data were not used for model calibration and 
provide an independent model check. The 
concentrations of different chemicals are sig-
nificantly increased (by about a factor 2) com-
pared with those obtained after similar single 
exposures to the substances. Model predictions 
consistently overlap the data, and the inter-
actions are qualitatively forecasted correctly. 
The predictions are very good for benzene and 
toluene but overshoot the data for ethylbenzene 
and m-xylene. On average, the data means and 
prediction medians differ by about 25%. We 
also performed predictions for binary 100 ppm 
toluene and 200 ppm m-xylene coexposures 
or ternary toluene, ethylbenzene, and m-xy-
lene coexposures (100 ppm each) (Tardif et al. 
1996). The results were similar to those of 
Figure 7 [Supplemental Material, Figures S1, 
S2 (http://dx.doi.org/10.1289/ehp.1103510)].
Exploration of modeling alternatives. In 
order to check whether the model predictions 
would be altered significantly by the addition 
of a minor metabolic pathway or by the pos-
sibility of competition with the metabolites 
formed, we studied type II and type III global 
models (see Figures 3, 4). Using model type 
II had little impact on the predictions. Model 
type III was able to partly improve them, in 
some cases removing or even reversing the 
biases seen in Figure 7. {Results of this analysis 
[see Supplemental Material, Figures S3–S8 
(http://dx.doi.org/10.1289/ehp.1103510)] 
and model and input files that can be used to 
perform new simulations with GNU MCSim 
are available at http://www.gnu.org/  software/
mcsim/  supplement_EHP_2011.tar.gz.} 
Neither model gave a consistent improvement 
in predictions, but with adequate parameter 
values they could potentially lead to a refined 
prediction of interactions.
Discussion
We used a modeling framework theoretically 
able to predict complex metabolic interactions 
among an unlimited number of drugs, envi-
ronmental and workplace contaminants, and 
food-borne natural chemicals (Bois 2009b, 
2009c). The first component of this approach 
is to integrate it in a PBPK framework. It is 
well known that metabolic interactions are 
nonlinear phenomena that depend on inter-
nal concentrations at the site of metabolism 
(Haddad et al. 2001; Yang 2010; Yang et al. 
1995). PBPK models are becoming generic, at 
least in their transport components, and offer a 
consistent solution to that question even when 
a large number of substances are investigated 
jointly (Bois et al. 2010; Bouvier d’Yvoire 
et al. 2007). Still, metabolic pathway model-
ing is not yet generic, even though it is an 
important component of PBPK models. The 
development of a library of quantitative SBML 
models for substances of general interest, along 
the lines presented here, could provide a versa-
tile solution to that problem. SBML (Hucka 
et al. 2003) is one option among many, but 
it is well supported and is increasingly used 
by the systems biology community. SBML is 
also a high-level language developed explicitly 
to provide a common intermediate format for 
representing and exchanging models between 
simulation or analysis tools. That feature has 
greatly facilitated the development of our soft-
ware for the automatic generation of coupled 
model equations from a generic PBPK tem-
plate and a library of SBML models (Bois 
2009a). With the current computing capabili-
ties of personal computers, a mixture model 
Figure 6. Maximum posterior fit of the type I global model to venous blood concentration data [means ± 
SDs (data from Haddad et al. 2000)] on benzene (A), toluene (B), ethylbenzene (C), and m-xylene (D) in rats 
after a single chemical exposure to 50 ppm, 100 ppm, or 200 ppm.
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for about 100 substances can simulate a full 
day in a few seconds of computer time.
The use of reaction microconstants is an 
important feature of our approach. This may be 
seen as a step back to pre-Michaelian enzyme 
kinetics, but there are three arguments in its 
favor. First, Michaelis-Menten kinetics are an 
approximation (Bardsley et al. 1980; Hill et al. 
1977), and current computing and experi-
mental capabilities do not need to rely on an 
approximation. Second, microconstant for-
mulations permit a prediction of inter  actions 
from first principles (Luecke and Wosilait 
1979) without resorting to empirical inter-
action constants (usually denoted as ki) for each 
pair of chemicals considered. That simplifies 
modeling considerably: to model any mixture, 
it is enough to draw the individual metabolic 
schemes of its constituents and write their joint 
equation system. The same metabolic path-
ways and parameters values can be reused for 
different mixtures. Finally, our approach is in 
the long run more parsimonious in terms of 
parameters. The Michaelis-Menten formulation 
requires two parameters per chemical and per 
reaction (Vmax and Km) and usually two ki for 
each pair of interacting substances. The number 
of ki parameters therefore grows with the square 
of the number n of substances in the mixture. 
Our approach needs only three microconstants 
(k1, k2, and k3) per chemical and per reaction, 
whatever the complexity of the mixture, and the 
number of parameters grows only linearly with 
it. With four substances, 20 parameters are clas-
sically “needed,” whereas our approach requires 
only 12. The corresponding figures for a mix-
ture of 50 substances are 2,550 versus 150. A 
little used implication of the Michaelian com-
petitive inhibition model is that the   parameters 
ki are equal to the Km of each chemical (Luecke 
and Wosilait 1979), but that is still an approxi-
mation, without the flexibility to go beyond 
simple competition or the simplicity of our 
model building approach.
Yet, the use of fundamental constants has 
drawbacks. Although values for Vmax, Km, and 
ki are routinely available, values for k1, k2, and 
k3 are not; we had to obtain them using model 
calibration. Microconstant values could be 
obtained from specific experimental proto-
cols or quantum chemistry modeling (work 
in progress in our laboratory). The Michaelis-
Menten approximation also gives reasonable 
results in many cases when studying one or 
two substances. It is interesting to note that 
the question of interactions has been reduced 
in the drug industry to that of “drug–drug” 
interactions, even if that is a severe reduction 
of the whole question. Finally, experimentally 
determined ki do not need to describe a precise 
mechanism and can approximate a variety of 
them. In contrast, our approach requires a pre-
cise definition of the   hypothesized   interaction 
mechanisms.
To demonstrate our approach, we con-
fronted its predictions with well-studied data. 
The BTEX case, even if on a limited number 
of chemicals, is important and has been well 
studied (Dennison et al. 2003; Haddad et al. 
1999; Tardif et al. 1996, 1997). It was dif-
ficult, however, to obtain precise values for k1, 
k2, and k3 from whole-body kinetic data (see 
Figure 6, Table 3). This comes as little surprise 
because Michaelis and Menten developed their 
simplification precisely to address that diffi-
culty. We were able to set an informative prior 
for k3 on the basis of published Vmax values for 
benzene, toluene, ethylbenzene, and m-xylene. 
For k1 and k2, we resorted to wide ranges, with 
upper bounds imposed by physical constraints 
on diffusions (Segel 1975). Their ratio, how-
ever, is reasonably well identified. The model 
fit after calibration is excellent, and little would 
be gained by a multilevel analysis (Bois et al. 
1996). In addition, the Km values implied by 
the posterior distributions of the microcon-
stants are reasonably close to previous esti-
mates [see Supplemental Material, Table S3 
(http://dx.doi.org/10.1289/ehp.1103510)].
Overall, our results show that a microcon-
stant-based model (model I) gives a correct 
qualitative picture of the interactions observed 
in BTEX mixtures. Quantitatively, about 50% 
of the interaction effects are predicted. We did 
not have sufficient information to precisely cal-
ibrate improved models of BTEX metabolism. 
We know, however, that such models surely 
exist. The initial steps of benzene metabolism 
involve CYP-dependent oxidation. CYP2E1 
and to some extent CYP2B1 are likely to be the 
main enzymes for benzene metabolism at high 
levels of exposure (Gut et al. 1996; Nakajima 
1997). A second high-affinity, low-capacity 
CYP2F1 or CYP2A13 pathway has been 
Figure 7. Blood kinetics of benzene (A), toluene (B), ethylbenzene (C), and m-xylene (D) after exposure to 
a quaternary mixture of 100 ppm of benzene and 50 ppm of each of the other three BTEX components. The 
box plots display the interquartile range (IQR) of the type I global model predictions (without any fitting to 
the mixture data). The boxes correspond to the 25th and 75th percentiles, the horizontal lines within the 
boxes indicate median concentrations and the upper end of whisker is the value below 75th percentile 
plus 1.5 × IQR, while the lower end of whisker is the value above 25th percentile minus 1.5 × IQR. The 
blue circles represent experimental data for five rats, and the solid blue lines give their means (data from 
Haddad et al. 1999). The dashed lines indicate mean experimental venous concentrations of each chemical 
when administered alone at the same level in air (i.e., without interactions) (data from Haddad et al. 2000). 
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proposed (Rappaport et al. 2009, 2010). We 
performed a sensitivity analysis of the impact of 
model structure with models II and III, which 
include alternative pathways and competitions 
between parents and metabolites. Accounting 
for minor pathways and secondary metabolism 
could clearly improve predictions of BTEX 
interactions, but we did not get dramatic 
changes indicative of a strong sensitivity to 
secondary phenomena. Our description of the 
liver is also simplistic and could be improved 
with a finer description of liver zonation-
  dependent metabolism (Andersen et al. 1997; 
Sheikh-Bahaei et al. 2009; Wambaugh and 
Shah 2010). It would not be difficult to extend 
our models with more enzymes and complex 
reactions mechanisms (including enzymatic 
induction) (Bois 2009c; Luke et al. 2010) or 
specific early   toxicity pathways.
Conclusions
A first-principles, systems biology, or mecha-
nism-based approach for large-scale prediction 
of metabolic interactions is technically feasible 
and worth exploring. Generic PBPK models 
are an essential ingredient of it. The predic-
tions made here for the BTEX case were basi-
cally correct, if not perfect. Better experimental 
or modeling ways to obtain kinetic microcon-
stants should be explored. This agenda applies 
to systems biology as a whole, and tools are 
becoming available to calibrate cell-level mod-
els (Bois 2009a; Vyshemirsky and Girolami 
2008). The major conclusion of this work is 
that detailed quantitative understanding of 
the metabolic and toxicity pathways of indi-
vidual chemicals should be sufficient to predict 
interactions in complex mixtures. Using the 
framework we present here, predictive models 
for arbitrary mixtures can be automatically 
generated on the basis of a library of mod-
els for individual substances. That approach 
is entirely congruent with trend to develop 
and share modular libraries of systems biology 
models (Le Novere et al. 2006).
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